FONAR Corporation (FONR) 

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Show less

Over the last 12 months, insiders at FONAR Corporation have bought $0 and sold $0 worth of FONAR Corporation stock.

On average, over the past 5 years, insiders at FONAR Corporation have bought $131,315 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 3,400 shares for transaction amount of $48,144 was made by Bonanni Luciano B (Exec VP, COO & PFO) on 2022‑09‑30.